S. Bovismorbificans isolates used in this study.

The table summarizes properties of the isolates used in this study, including the presence or absence of ROD13, -14 and -34, the presence of the virulence plasmid pVIRBov and the size of the accessory genome in each of the addtional 17 Illumina-sequenced S. Bovismorbificans genomes obtained in comparison to strain 3114.#M = months, Y = years ; outcome 1 = death, 2 = survived, 3 = unknown, ND = no data; N/A = not applicable; resistance profile = sulphamethoxazole (RL), cefuroxime (CXM), rifampicin (RD), amocixillin (AML), gentamicin (CN), trimethoprim (W), chloramphenicol (C), tetracycline (TET), streptomycin (S); ST refers to the MLST sequence type as determined by Illumina sequencing and sequencing of PCR amplicons,*SLV = Single Locus Variant; ROD13/ = partial or different ROD present.